F
$ Value
$48K
Shares
16,401
Price
$3
Filed
Dec 3
Insider
Name
Freeman Kevin Lee
Title
Chief Commercial Officer
CIK
0001945797
Roles
Officer
Transaction Details
Transaction Date
2025-12-01
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
358,686
Footnotes
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Filing Info
Freeman Kevin Lee's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-01 | HCAT | F | $48K |
| 2025-09-02 | HCAT | F | $15K |
| 2025-06-02 | HCAT | F | $17K |
Other Insiders at HCAT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Llewelyn Linda
Chief People Officer
|
— | — | 2026-03-02 |
| Gallagher Duncan | — | — | 2026-02-17 |
| Larson-Green Julie | — | — | 2026-03-01 |
|
Alger Jason
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Landry Benjamin
General Counsel
|
— | — | 2026-03-02 |
|
Albert Benjamin
CEO
|
— | — | 2026-03-10 |